Literature DB >> 2203319

Lupus-associated protein-losing enteropathy.

D A Perednia1, N A Curosh.   

Abstract

Fourteen cases of primary lupus-associated protein-losing enteropathy have now been reported in the English-language literature. These cases were reviewed to find any consistent pattern of presentation. Lupus-associated protein-losing enteropathy typically occurs in young women, and is characterized by the onset of profound edema and hypoalbuminemia. In many cases it is the first obvious manifestations of systemic lupus erythematosus. Diarrhea is present about 50% of the time, but steatorrhea is absent. Diagnosis of protein-losing enteropathy can be successfully made by radioisotopic studies or 24-hour stool alpha 1-antitrypsin clearance. A normal lymphocyte count, elevated serum cholesterol, and absence of lymphangiectasia on intestinal biopsy help distinguish lupus-associated protein-losing enteropathy from protein-losing enteropathies due to direct or indirect lymphatic obstruction. Normal endoscopy and mucosal biopsy can rule out protein loss due to mucosal disruption. Prognosis appears to be excellent with corticosteroids, although other immunosuppressive therapies have been successfully used. A typical and illustrative case is presented as a focal point for review and discussion.

Entities:  

Mesh:

Year:  1990        PMID: 2203319

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  11 in total

1.  Protein-losing gastroenteropathy associated with primary Sjögren's syndrome: a characteristic oriental variant.

Authors:  Takao Nagashima; Motoaki Hoshino; Shin Shimoji; Noritsugu Morino; Takeshi Kamimura; Hitoaki Okazaki; Seiji Minota
Journal:  Rheumatol Int       Date:  2008-11-29       Impact factor: 2.631

2.  Protein-losing enteropathy and pancreatic involvement in a case of connective tissue disease.

Authors:  T Kashihara; E Fujimori; A Oki; T Itoh; K Hashimoto; K Kotani; H Fukuda; H Tako; F Kawakami; G Okuno
Journal:  Gastroenterol Jpn       Date:  1992-04

3.  Clinical characteristics of concurrent and sequentially presented lupus-related protein-losing enteropathy: what are their differences?

Authors:  Siu-Tong Law; Kwok Man Ma; Kin Kong Li
Journal:  Rheumatol Int       Date:  2012-01-05       Impact factor: 2.631

Review 4.  Lupus protein-losing enteropathy (LUPLE): a systematic review.

Authors:  Sultan M Al-Mogairen
Journal:  Rheumatol Int       Date:  2011-02-23       Impact factor: 2.631

Review 5.  Gut microbiome and autoimmune disorders.

Authors:  Walaa Abdelaty Shaheen; Mohammed Nabil Quraishi; Tariq H Iqbal
Journal:  Clin Exp Immunol       Date:  2022-08-19       Impact factor: 5.732

6.  Protein-losing enteropathy associated with systemic lupus erythematosus: response to cyclophosphamide.

Authors:  Gláucio R Werner de Castro; Simone Appenzeller; Manoel B Bértolo; Lílian Tereza Lavras Costallat
Journal:  Rheumatol Int       Date:  2004-07-13       Impact factor: 2.631

7.  Outcome of surgical resection for protein-losing enteropathy in systemic lupus erythematosus.

Authors:  Yuh-Feng Wang; Kuo-Chih Tseng; Jainn-Shiun Chiu; Mei-Hua Chuang; Mei-Ing Chung; Ning-Sheng Lai
Journal:  Clin Rheumatol       Date:  2008-05-24       Impact factor: 2.980

8.  Lymphocytic enterocolitis in systemic lupus erythematosus.

Authors:  Mohamed O Hegazi; Salem F Owayed; Mohamed Mourou; Munish Joneja; Anant Mashankar
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

9.  Factors related to outcomes in lupus-related protein-losing enteropathy.

Authors:  Doo-Ho Lim; Yong-Gil Kim; Seung-Hyeon Bae; Soomin Ahn; Seokchan Hong; Chang-Keun Lee; Bin Yoo
Journal:  Korean J Intern Med       Date:  2015-10-30       Impact factor: 2.884

10.  Nutritional therapy and effect assessment of infants with primary intestinal lymphangiectasia: Case reports.

Authors:  Suyun Li; Xiaoqian Liu; Yuan He; Qianyu Li; Linlin Ji; Wenbin Shen; Guansheng Tong
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.